期刊文献+

宫颈癌筛查研究进展 被引量:14

New Progress in Cervical Cancer Screening
下载PDF
导出
摘要 宫颈癌是女性生殖系统最常见的恶性肿瘤,是世界卫生组织唯一建议在世界范围内开展筛查的恶性肿瘤,各个国家和地区宫颈癌筛查方案不尽相同,目前的筛查方案主要有:巴氏涂片法、液基细胞学检查、人乳头瘤病毒DNA(HPV-DNA)检测法及肉眼检查等。推行合理筛查方案对各个地区的宫颈癌及其癌前病变的预防工作极为重要。目前宫颈癌筛查也存在一些问题,如筛查人群、筛查间隔时间和筛查方案等,就目前宫颈癌筛查存在的问题及各个方案的应用及联合应用的可行性、优缺点和新进展进行论述。 Cervical cancer is one of the most common malignant tumors in gynecology,which is the only cancer recommended by The World Health Organization to start screening throughout the world.The screening strategy is different from countries.The current methods are Pap smear,liquid-based cytology,HPV-DNA testing,visual inspection (VIA),visual inspection with Lugol's iodine(VILI) and so on.It is considerable to apply the reasonable strategy in different districts.Still several problems exist,such as screening crowd,screening interval and screening method and so on.This paper reviews these exist problems and the research progress in the current cervical screening methods and the feasibility of the combination of different screening methods.
出处 《国际妇产科学杂志》 CAS 2010年第5期314-317,共4页 Journal of International Obstetrics and Gynecology
关键词 宫颈肿瘤 宫颈上皮内瘤样病变 宫颈非典型增生 乳头状瘤病毒科 Uterine cervical neoplasms Cervical intraepithelial neoplasia Uterine cervical dysplasia Papillomaviridae
  • 相关文献

参考文献19

  • 1Saslow D,Runowicz CD,Solomon D,et al.American Cancer Society guideline for the early detection of cervical neoplasia and cancer[J].CA Caneer J Clin,2002,52(6):342-362.
  • 2ACOG Committee on Practice Bulletins.ACOG Practice Bulletin:clinical management guidelines for obstetrician-gynecologists.Number 45,August 2003.Cervical cytology screening (replaces committee opinion 152,March 1995)[J].Obstet Gynecol,2003,102(2):417-427.
  • 3Walker P.The English National Health Service Cervical Screening Programme-approach to new technologies and quality assurance[J].J Low Genit Tract Dis,2005,9(2):118-123.
  • 4Garland SM,Brotherton JM,Skinner SR,et al.Human papillomavirus and cervical cancer in Australasia and Oceania:risk-factors,epidemiology and prevention[J].Vaccine,2008,26(Suppl 12):80-88.
  • 5Wright TC Jr.Cervical cancer screening in the 21st century:is it time to retire the PAP smear?[J].Clin Obstet Gynecol,2007,50 (2):313-323.
  • 6Mayrand MH,Duarte-Franco E,Rodrigues I,et al.Human papillomavirus DNA versus Papanicolanu screening tests for cervical cancer[J].N Engl J Med,2007,357(16):1579-1588.
  • 7Strander B,Andersson-Ellstrom A,Milsom I,et al.Liquid-based cytology versus conventional Papanicolanu smear in an organized screening program:a prospective randomized study[J].Cancer,2007,111 (5):285-291.
  • 8Davey E,Barratt A,Irwig L,et al.Effect of study design and quality on unsatisfactory rates,cytology classifications,and accuracy in liquid-based versus conventional cervical cytology:a systematic review[J].Lancet,2006,367(9505):122-132.
  • 9Celik C,Gezginc K,Toy H,et al.A comparison of liquid based cytology with conventional cytology[J],lnt J Gynaecol Obstet,2008,100(2):163-166.
  • 10Arbyn M,Sasieni P,Meijer C J,et al.Chapter 9:Clinical applications of HPV testing:a summary of recta-analyses[J].Vaccine,2006,24(Suppl 3):78-89.

同被引文献115

引证文献14

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部